Oncology Search
Oncology Oncology

Conference Reports

European Society for Medical Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer (WCGC)
Barcelona
03 July 2019 - 06 July 2019
24th European Hematology Assication (EHA) Congress
Amsterdam
13 June 2019 - 16 July 2019
American Society of Clinical Oncology (ASCO) 2019 Annual Meeting
Chicago, Illinois, US
31 May 2019 - 04 June 2019
European Lung Cancer Congress 2019 (ELCC 2019)
Geneva, Switzerland
10 April 2019 - 13 April 2019
American Association for Cancer Research (AACR) Annual Meeting 2019
Atlanta, Georgia
29 March 2019 - 03 April 2019
14th International Symposium on Healthy Aging
16 March 2019 - 17 March 2019
2019 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 2019)
San Francisco, California
14 February 2019 - 16 February 2019
Uro-Oncology Asia 2019
19 January 2019 - 20 January 2019
2019 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI 2019)
San Francisco, California
17 January 2019 - 19 January 2019
San Antonio Breast Cancer Symposium (SABCS) 2018
San Antonio, Texas
04 December 2018 - 08 December 2018
60th American Society of Hematology (ASH) Annual Meeting and Exposition
San Diego, California, US
01 December 2018 - 04 December 2018
ESMO Asia 2018 Congress
Singapore
23 November 2018 - 25 November 2018
12th IDF-WPR Congress & 10th AASD Scientific Meeting
Kuala Lumpur
22 November 2018 - 25 November 2018
European Society for Medical Oncology (ESMO) 2018 Congress
Munich
19 October 2018 - 23 October 2018
World Cancer Congress
Kuala Lumpur
01 October 2018 - 04 October 2018
International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer (WCLC 2018)
Toronto
23 September 2018 - 26 September 2018
22nd International AIDS Conference (AIDS 2018)
Amsterdam, the Netherlands
23 July 2018 - 27 July 2018
34th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE 2018)
Barcelona, Spain
01 July 2018 - 04 July 2018
23rd Congress of the European Hematology Association (EHA 2018)
Stockholm, Sweden
14 June 2018 - 17 June 2018
American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
Chicago, Illinois
01 June 2018 - 05 June 2018
23rd Hong Kong Medical Forum
05 May 2018 - 06 May 2018
American Association for Cancer Research Annual Meeting (AACR 2018)
Chicago, Illinois, US
14 April 2018 - 18 April 2018
European Lung Cancer Congress (ELCC) 2018
Geneva
11 April 2018 - 14 April 2018
11th European Breast Cancer Conference (EBCC 2018)
Barcelona, Spain
21 March 2018 - 23 March 2018
European Association of Urology (EAU) 2018 Congress
Copenhagen
16 March 2018 - 19 March 2018
2018 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU 2018)
San Francisco, California
08 February 2018 - 10 February 2018
2018 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
San Francisco, California, US
18 January 2018 - 20 January 2018
Hong Kong Society of Uro-Oncology Annual Scientific Meeting 2018
Hong Kong
20 January 2018 - 20 January 2018
59th American Society of Hematology (ASH) Annual Meeting and Exposition
Atlanta, Georgia, US
09 December 2017 - 12 December 2017
2017 San Antonio Breast Cancer Symposium (SABCS)
San Antonio, Texas, US
05 December 2017 - 09 December 2017
ESMO Asia 2017 Congress
Singapore
17 November 2017 - 19 November 2017
2017 Annual Meeting of American Society for Radiation Oncology (ASTRO)
San Diego, California, US
24 September 2017 - 27 September 2017
International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC)
Yokohama, Japan
15 October 2017 - 18 October 2017
European Society for Medical Oncology (ESMO) Congress 2017
Madrid, Spain
08 September 2017 - 12 September 2017
15th Urological Association of Asia Congress (UAA 2017)
04 August 2017 - 06 August 2017
European Society for Medical Oncology (ESMO) 19th World Congress on Gastrointestinal Cancer (WCGC)
Barcelona
28 June 2017 - 01 July 2017
22nd Congress of European Hematology Association (EHA)
Madrid
22 June 2017 - 25 June 2017
American Society of Clinical Oncology (ASCO) 2017 Annual Meeting
Chicago, Illinois, US
02 June 2017 - 06 June 2017
European Lung Cancer Conference (ELCC) 2017
Geneva
05 May 2017 - 08 May 2017
American Society of Clinical Oncology (ASCO) 2017 Genitourinary Cancers Symposium
Orlando, Florida
16 February 2017 - 18 February 2017
7th Association of South-East Asian Pain Societies (ASEAPS) Congress 2017
Yangon
16 February 2017 - 19 February 2017
26th Conference of the Asian Pacific Association for the Study of the Liver (APASL)
Shanghai, China
15 February 2017 - 19 February 2017
2017 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
19 January 2017 - 21 January 2017
European Cancer Congress 2017 (ECCO 2017)
Amsterdam
27 January 2017 - 30 January 2017
European Society for Medical Oncology (ESMO) Asia 2016 Congress
Singapore
16 December 2016 - 19 December 2016
American Society of Hematology (ASH) 58th Annual Meeting
San Diego, California
03 December 2016 - 06 December 2016
2016 San Antonio Breast Cancer Symposium (SABCS)
San Antonio, Texas
06 December 2016 - 10 December 2016
World Conference on Lung Cancer (WCLC) 2016
Vienna
04 December 2016 - 07 December 2016
European Society for Medical Oncology (ESMO) Congress 2016
Copenhagen
07 October 2016 - 11 October 2016
14th Urological Association of Asia Congress (UAA 2016)
Singapore
20 July 2016 - 24 July 2016
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Low-dose adjuvant ipilimumab improves OS in high-risk melanoma
Elaine Soliven, 28 Jun 2019
Adjuvant treatment with ipilimumab significantly improved overall survival (OS) among patients with resected high-risk melanoma compared with high-dose interferon-α2b (HDI*), according to final results of the North American Intergroup E1609** trial presented at ASCO 2019.
Maintenance olaparib yields survival gains in BRCA-mutated metastatic pancreatic cancer
Jairia Dela Cruz, 03 Jul 2019
Use of olaparib in the maintenance setting prolongs progression-free survival in patients with a germline BRCA mutation and metastatic pancreatic cancer as compared with placebo, according to the results of the phase III POLO trial.
Neoadjuvant T-DM1 + pertuzumab tied to elevated risk of EFS events in HER2+ breast cancer
Elaine Soliven, 18 Jun 2019
Neoadjuvant treatment with trastuzumab emtansine (T-DM1) plus pertuzumab led to an elevated risk of 3-year event-free survival (EFS) events in patients with HER2-positive breast cancer, according to a secondary analysis of the KRISTINE* trial presented at ASCO 2019.
Taxane-based TPEx shows promise for head, neck cancer
Audrey Abella, 14 Jun 2019
The taxane-based TPEx regimen demonstrated encouraging overall survival (OS) benefit for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) compared with the fluorouracil (5FU)-based EXTREME regimen, according to the results of the TPExtreme* trial presented at ASCO 2019.